Lexicon Pharmaceuticals (NASDAQ:LXRX) adds US$51m to market cap in the past 7 days, though investors from five years ago are still down 69%

By Yahoo! Finance | Jun 11, 2024 at 08:50 AM EST

Long term investing can be profitable, but not always immune to losses. For instance, Lexicon Pharmaceuticals' stock has declined significantly over five years, indicating high risk due to low revenue and profitability. Shareholders must consider company stability before investing.

Did you find this insightful?

Bad

Just Okay

Amazing

We are preparing, please wait

New Alert

Select an alert type

Sentiment Spike

Send email alert if news sentiment changes significantly

Mentions Spike

Send email alert if has a surge in mentions

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.